Ronald Blue Trust, Inc. Viatris Inc Transaction History

Ronald Blue Trust, Inc.

$7.7 Billion
Q4 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 4,347 shares of VTRS stock, worth $49,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,347

Previous 11,380 61.8%

Holding current value

$49,034

Previous $141,000 61.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$11.32 - $13.37 $79,613 - $94,031	-7,033 Reduced 61.8%	4,347 $54,000
Q4 2024 Jan 22, 2025	BUY	$11.32 - $13.37 $39,846 - $47,062	3,520 Added 44.78%	11,380 $141,000
Q3 2024 Oct 17, 2024	BUY	$10.32 - $12.13 $20,474 - $24,065	1,984 Added 33.76%	7,860 $91,000
Q2 2024 Jul 18, 2024	BUY	$10.05 - $12.02 $9,537 - $11,406	949 Added 19.26%	5,876 $62,000
Q1 2024 May 01, 2024	SELL	$11.27 - $13.53 $47,863 - $57,461	-4,247 Reduced 46.29%	4,927 $58,000
Q4 2023 Jan 18, 2024	BUY	$8.77 - $10.85 $6,288 - $7,779	717 Added 8.48%	9,174 $90,000
Q3 2023 Oct 11, 2023	BUY	$9.59 - $11.35 $45,370 - $53,696	4,731 Added 126.97%	8,457 $84,000
Q2 2023 Jul 14, 2023	SELL	$9.02 - $10.29 $33,734 - $38,484	-3,740 Reduced 50.09%	3,726 $35,000
Q1 2023 Apr 17, 2023	SELL	$9.2 - $12.26 $4,618 - $6,154	-502 Reduced 6.3%	7,466 $83,000
Q4 2022 Jan 17, 2023	BUY	$8.72 - $11.56 $32,307 - $42,829	3,705 Added 86.91%	7,968 $68,000
Q3 2022 Oct 21, 2022	BUY	$8.48 - $11.13 $398 - $523	47 Added 1.11%	4,263 $44,000
Q2 2022 Aug 09, 2022	BUY	$9.95 - $12.27 $41,949 - $51,730	4,216 New	4,216 $46,000

Others Institutions Holding VTRS

# of Institutions

1,095

Shares Held

965M

Call Options Held

2.69M

Put Options Held

2.34M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Viatris Inc Transaction History